Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
04/06/2011 | EP2305291A1 Use of proteasome inhibitors for the treatment of HIV infections |
04/06/2011 | EP2305286A2 Treatment for Alzeimer's disease |
04/06/2011 | EP2305282A2 Prevention and treatment of amyloidogenic disease |
04/06/2011 | EP2305281A1 Composition comprising a hot water extract of hemerocallis plants, said composition being effective in treating fatigue by having antidepressant properties or by improving sleep |
04/06/2011 | EP2305276A2 Processed lipoaspirate cells for use in therapy |
04/06/2011 | EP2305274A1 Use of WNT stimulators for treating demyelinating diseases |
04/06/2011 | EP2305264A1 Spicamycin derivatives for use in decreasing or preventing pain |
04/06/2011 | EP2305262A1 Selective PDE9A inhibitors as medicaments for the improvement of cognitive processes |
04/06/2011 | EP2305260A1 Psychotropic agent and health food containing benzylisoquinoline derivative |
04/06/2011 | EP2305258A2 Inhibition of neuronal damage |
04/06/2011 | EP2305253A1 Use of pramipexole to treat amyotrophic lateral sclerosis |
04/06/2011 | EP2305252A1 Use of pramipexole to treat amyotrophic lateral sclerosis |
04/06/2011 | EP2305251A2 Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of sexual disorder |
04/06/2011 | EP2305248A1 Substituted phenethylsulfones and method of reducing tnf-alpha levels |
04/06/2011 | EP2305230A1 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
04/06/2011 | EP2305229A1 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
04/06/2011 | EP2305225A1 Use of (1S, 2R) enantiomer of milnacipran for the preparation of a medicine |
04/06/2011 | EP2305218A1 Controlled release hydrocodone formulations |
04/06/2011 | EP2305213A2 The treatment of small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
04/06/2011 | EP2305194A1 Sustained analgesia achieved with buprenorphine |
04/06/2011 | EP2305193A1 Sustained analgesia achieved with buprenorphine |
04/06/2011 | EP2305192A1 Sustained analgesia achieved with buprenorphine |
04/06/2011 | EP2305191A1 Sustained analgesia achieved with buprenorphine |
04/06/2011 | EP2303926A1 Immunogenic memapsin 2 -secretase peptides and methods of use |
04/06/2011 | EP2303895A1 Thiazolyl- and oxazolyl-isoquinolinones and methods for using them |
04/06/2011 | EP2303884A1 Adenine receptor ligands |
04/06/2011 | EP2303872A1 Isoxazole derivatives and their use as metabotropic glutamate receptor potentiators |
04/06/2011 | EP2303871A1 Pyrrolidin-3-ylmethyl-amine as orexin antagonists |
04/06/2011 | EP2303867A1 Pyrazinone modulator of corticotropin-releasing factor receptor activity |
04/06/2011 | EP2303863A1 5- and 6-membered heterocyclic compounds |
04/06/2011 | EP2303857A1 Cyclic sulfones with aminobenzyl substitution useful as bace inhibitors |
04/06/2011 | EP2303853A2 Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents |
04/06/2011 | EP2303851A1 Novel phenolic and catecholic amines and prodrugs thereof |
04/06/2011 | EP2303846A1 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
04/06/2011 | EP2303845A2 Bi-and polycyclic substituted isoquinoline and isoquinoline derivatives as rho kinase inhibitors |
04/06/2011 | EP2303407A1 Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells |
04/06/2011 | EP2303392A1 Pharmacokinetics of iontophoretic sumatriptan administration |
04/06/2011 | EP2303330A1 Pharmaceutical compositions for treatment of parkinson's disease |
04/06/2011 | EP2303325A2 Inhibition of emmprin to treat multiple sclerosis |
04/06/2011 | EP2303315A1 Method for treating disease characterized by plaque |
04/06/2011 | EP2303311A1 Use of angiogenin or angiogenin agonists for treating diseases and disorders |
04/06/2011 | EP2303309A2 Treatment of mitochondrial diseases with an erythropoietin mimetic |
04/06/2011 | EP2303284A2 Methods of treatment of bipolar disorder |
04/06/2011 | EP2303272A1 Sofinicline (abt-894 ) for attention-deficit/hyperactivity disorder |
04/06/2011 | EP2303263A1 Use |
04/06/2011 | EP2303261A1 Use of cyclolignans for the treatment of a hyperactive immune system |
04/06/2011 | EP2094675B1 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one |
04/06/2011 | EP1828151B1 Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer's disease |
04/06/2011 | EP1814849B1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
04/06/2011 | EP1685832B1 Nerve regeneration promoters |
04/06/2011 | EP1628968B1 4-imidazolin-2-one compounds |
04/06/2011 | EP1558259B1 Urea derivatives as IL-8 receptor antagonists |
04/06/2011 | EP1519939B9 N-aryl diazaspirocyclic compounds and methods of preparation and use thereof |
04/06/2011 | EP1404324B2 Prodrugs of gaba analogs, compositions and uses thereof |
04/06/2011 | EP1328236B1 Methods of decreasing or preventing pain using spicamycin derivatives |
04/06/2011 | EP1303522B1 Biologically active macrolides, compositions, and uses thereof |
04/06/2011 | EP1255556B1 Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein c (apc) |
04/06/2011 | CN201782997U Novel vehicle-mounted air purifier |
04/06/2011 | CN201782427U Novel healthcare pillow |
04/06/2011 | CN1812980B Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
04/06/2011 | CN1762495B Long acting sustained-release formulation containing dopamine-receptor stimulant medicine and its preparation process |
04/06/2011 | CN1658893B G-type peptides to ameliorate atherosclerosis |
04/06/2011 | CN1376146B Solid-state form of celecoxil having enhanced bioavailability |
04/06/2011 | CN102007133A 3-phenylpyrazolo[5,1-b]thiazole compounds |
04/06/2011 | CN102007129A Derivatives of galantamine as pro-drugs for the treatment of human brain diseases |
04/06/2011 | CN102007121A 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands |
04/06/2011 | CN102007117A Tertiary amine derivatives as phosphodiesterase-4 inhibitors |
04/06/2011 | CN102007102A Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto |
04/06/2011 | CN102006882A Treating neurodegenerative diseases with progranulin (pgrn) |
04/06/2011 | CN102002493A Application of small RNA-326 in preparation of medicament |
04/06/2011 | CN102002441A Plant balm for improving physical and mental harmonious degree and preparation method thereof |
04/06/2011 | CN102002104A Anti-VEGF monoclonal antibody and medicinal composition containing same |
04/06/2011 | CN102002052A Ginkgolides K and compound thereof as well as preparation method and use thereof |
04/06/2011 | CN102002050A Bisbenzylisoquinoline derivative and preparation and application thereof |
04/06/2011 | CN102002049A Antigen and preparation method and application thereof |
04/06/2011 | CN102001959A Medicinal crystal as well as preparation method and application thereof |
04/06/2011 | CN102000345A Complex folic acid/beta-cyclodextrin composite and preparation method thereof |
04/06/2011 | CN102000336A Carbostyril derivatives and mood stabilizers for treating mood disorders |
04/06/2011 | CN102000334A Compound preparation for treating depression |
04/06/2011 | CN102000318A Pharmaceutical composition for treating facial paralysis and preparation method thereof |
04/06/2011 | CN102000315A Traditional Chinese medicinal composition for treating dizziness and preparation method thereof |
04/06/2011 | CN102000314A Detection method of Chinese medicine composition for treating dizziness |
04/06/2011 | CN102000298A Medicament for treating headache during menstruation |
04/06/2011 | CN102000288A Traditional Chinese medicine for treating neurasthenia and insomnia |
04/06/2011 | CN102000286A Traditional Chinese medicine preparation for treating polyneuritis |
04/06/2011 | CN102000275A Medicinal composition for treating children with tic disorders and preparation method thereof |
04/06/2011 | CN102000274A Sugar-free fire clearing Chinese herbal granules and preparation method thereof |
04/06/2011 | CN102000266A Medicament for treating cardiovascular and cerebrovascular diseases and brain paralysis and preparation method thereof |
04/06/2011 | CN102000264A Composition for treating climacteric syndrome as well as preparation method and detection method thereof |
04/06/2011 | CN102000226A Medicine for treating hemiplegy |
04/06/2011 | CN102000225A Health care medicament for sobering, removing alcoholism and preventing and treating fatty liver and preparation method thereof |
04/06/2011 | CN102000223A Traditional Chinese medicine compound preparation for treating vascular dementia as well as preparation method and application thereof |
04/06/2011 | CN102000212A Method for preparing composite earthworm health-care product |
04/06/2011 | CN102000211A Traditional Chinese medicine composition for improving sleep and treating impotence and premature ejaculation, and preparation method thereof |
04/06/2011 | CN102000193A Traditional Chinese medicine for treating insomnia |
04/06/2011 | CN102000186A Quick-acting drug abstinence de-addiction pure Chinese medicinal preparation and preparation method thereof |
04/06/2011 | CN102000184A Method for extracting substances for relieving alcoholism from honey trees |
04/06/2011 | CN102000152A Preparation method for composite gingkgo health product |
04/06/2011 | CN102000150A External liniment for treating facial neuritis |
04/06/2011 | CN102000148A Application of scutelaria baicalemis and baicalin in preparing medicament for improving learning memory and treating Alzheimer's disease |